Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland

Troy Lionberger, PhD
Chief Business Officer at A-Alpha Bio
Speaker

Profile

Troy leads Business Development and Alliance Management at A-Alpha Bio. He began his career at the bench after earning his PhD from the University of Michigan and completing a postdoctoral fellowship at UC Berkeley. Over nine years at Berkeley Lights, Troy held leadership roles across R&D, product strategy, and business development—ultimately driving commercial efforts that secured over $200M in deals spanning biopharma, agriculture, and industrial biotechnology. Prior to joining A-Alpha, he served as Chief Business Officer at Abbratech, where he led the company’s transition from a stealth-mode antibody discovery platform to a partner-facing biotech. Troy brings deep technical fluency and a proven ability to scale platform businesses through transformative partnerships.

Agenda Sessions

  • How Millions of Affinity Measurements Enable Predictive Multi-parameter Antibody Optimization in Weeks

    07:40